The North America bifurcation lesions market is expected to experience steady growth due to the increasing prevalence of coronary artery disease and the presence of well-established healthcare infrastructure. The United States and Canada are major contributors to the market in this region.
Asia Pacific:
The Asia Pacific bifurcation lesions market is projected to witness significant growth, primarily driven by the rising geriatric population and the increasing adoption of minimally invasive procedures in countries like China, Japan, and South Korea.
Europe:
In Europe, countries such as the United Kingdom, Germany, and France are expected to drive the growth of the bifurcation lesions market. This can be attributed to the growing awareness about cardiovascular diseases and the availability of advanced medical treatments in these countries.